Quick Answer
Cytosorbents Corp reported Cash And Cash Equivalents At Carrying Value of $6.25 million for the year ending 2025.
- Cytosorbents Corp showed an increase of +90.5% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from Cytosorbents Corp's annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2011: $1.19 million | Q1 2012: $1.80 million | Q2 2012: $1.74 million | Q3 2012: $2.06 million | Q1 2013: $1.37 million | Q2 2013: $1.87 million | Q3 2013: $2.35 million | Q1 2014: $6.42 million | Q2 2014: $4.88 million | Q3 2014: $433.4 thousand | Q1 2015: $10.42 million | Q2 2015: $8.02 million | Q3 2015: $7.39 million | Q1 2016: $3.54 million | Q2 2016: $8.67 million | Q3 2016: $6.38 million | Q1 2017: $3.24 million | Q2 2017: $16.40 million | Q3 2017: $15.40 million | Q1 2018: $21.09 million | Q2 2018: $25.28 million | Q3 2018: $24.91 million | Q4 2018: $22.37 million | Q1 2019: $19.65 million | Q2 2019: $16.34 million | Q3 2019: $15.98 million | Q1 2020: $26.39 million | Q2 2020: $35.11 million | Q3 2020: $87.98 million | Q1 2021: $68.47 million | Q2 2021: $65.61 million | Q3 2021: $61.04 million | Q1 2022: $43.02 million | Q2 2022: $30.16 million | Q3 2022: $22.55 million | Q1 2023: $19.05 million | Q2 2023: $13.15 million | Q3 2023: $8.36 million | Q1 2024: $8.61 million | Q2 2024: $8.46 million | Q3 2024: $5.69 million | Q1 2025: $11.59 million | Q2 2025: $10.20 million | Q3 2025: $7.54 million.
- Over the full 17 years of available data (2009 to 2025), Cytosorbents Corp's Cash And Cash Equivalents At Carrying Value has grown by 291.6%.
- Historical annual values: Fiscal year 2025: $6.25 million | Fiscal year 2024: $3.28 million | Fiscal year 2023: $14.13 million | Fiscal year 2022: $22.14 million | Fiscal year 2021: $52.14 million | Fiscal year 2020: $71.42 million | Fiscal year 2019: $12.23 million | Fiscal year 2018: $22.37 million | Fiscal year 2017: $17.32 million | Fiscal year 2016: $5.25 million | Fiscal year 2015: $5.32 million | Fiscal year 2014: $3.61 million | Fiscal year 2013: $2.18 million | Fiscal year 2012: $1.73 million | Fiscal year 2011: $1.19 million | Fiscal year 2010: $1.06 million | Fiscal year 2009: $1.60 million.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: